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ABSTRACT
The dual function mammalian DNA repair enzyme,
polynucleotide kinase (PNK), facilitates strand break
repair through catalysis of 50-hydroxyl phosphoryla-
tion and 30-phosphate dephosphorylation. We have
examined the relative activities of the kinase and
phosphatase functions of PNK using a novel assay,
which allows the simultaneous characterization of
both activities in processing nicks and gaps contain-
ingboth30-phosphateand50-hydroxyl.Undermultiple
turnover conditions the phosphatase activity of the
purified enzyme is significantly more active than its
kinase activity. Consistent with this result, phospho-
rylationofthe50-hydroxylisratelimitingincellextract
mediated-repair of a nicked substrate. On character-
izingtheeffectsofindividuallymutatingthetwoactive
sites of PNK we find that while site-directed mutage-
nesis of the kinase domain of PNK does not affect its
phosphatase activity, disruption of the phosphatase
domain also abrogates kinase function. This loss of
kinase function requires the presence of a 30-phos-
phate, but it need not be present in the same strand
break as the 50-hydroxyl. PNK preferentially binds
30-phosphorylated substrates and DNA binding to
the phosphatase domain blocks further DNA binding
by the kinase domain.
INTRODUCTION
Damage to DNA is a causative factor in aging and a number of
human disease processes including cancer. Single strand
breaks (SSB) are a common type of damage to DNA, which
can arise through both direct scission of the DNA backbone or
as intermediates in normal DNA metabolic processes, such
as replication and repair. Since strand breaks are both recom-
binogenic and cytotoxic, it is essential that they are repaired
promptly and efﬁciently. However for strand resynthesis and
ligation to proceed, the DNA termini must consist of a 30-
hydroxyl and a 50-phosphate. In practice, SSB often have alter-
native termini, which must be processed before repair can be
completed. 30-Phosphate termini are common and can arise
from a number of sources including reactive oxygen species,
ionising radiation (1), Tdp1 processing of stalled topoiso-
merase I complexes, such as are generated by the drug camp-
tothecin (2), and as intermediates in a sub-pathway of base
excision repair of oxidative base damage (3). 50-Hydroxyl ter-
mini are also commonly occurring products of strand scission
by e.g. ionising radiation (4) or camptothecin treatment (5).
First identiﬁed in the mid 1970s (6), mammalian polynu-
cleotide kinases (PNK) are bifunctional enzymes with both
50-kinase and 30-phosphatase activities (7,8). Human PNK is
a 57 kDa protein (9,10), which has been implicated in both
SSB repair and double strand break (DSB) repair via the non-
homologousend joining (NHEJ)pathway(11–14). PNKforms
multi-enzymecomplexes invivo with Polb,XRCC1and DNA
Ligase III (14) and Tdp1, XRCC1 and Ligase III (15). Each
of these complexes is necessary and sufﬁcient to carry out
particular sub-pathwaysofSSBrepair. Stable down-regulation
of PNK in human cells results in hypersensitivity to a number
of DNA damaging agents including ionising radiation, camp-
tothecin and H2O2 and also increases the spontaneous muta-
tion frequency (16). It is therefore likely that PNK is a key
player in protecting against both exogenous and endogenous
sources of DNA damage.
Mammalian PNK enzyme is monomeric in structure (17)
with the kinase and phosphatase domains being tightly asso-
ciatedandinseperablebyproteolysis,whilestillshowing some
ﬂexibility in orientation (18). The recent crystal structure of
mouse PNK revealed that the two active sites are situated on
the same side of the protein; however their physical separation
( 40 s)seemingly precludes the possibilitythat the enzyme is
able to simultaneously process 30-phosphate and 50-hydroxyl
termini when they are located in the same nick or small gap
(18). A key question is therefore how the dual activities of
PNK co-ordinate with each other. To address this, we have
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doi:10.1093/nar/gkl275used a novel system with a ﬂuorescently double-labelled sub-
strate, examining how the kinase and phosphatase activities
compare in processing SSB ﬂanked by botha 30-phosphate and
50-hydroxyl. We have also carried out individual site-directed
mutagenesis of the kinase and phosphatase active sites of
human PNK and show that while disruption of the kinase
domain leaves the phosphatase activity unaffected, mutation
of the phosphatase domain also abrogates the kinase activity
on model nicked and gapped substrates containing a 30-phos-
phate. To put our observations into a biological context we
have also characterized the repair of a model substrate by
human cell extracts.
MATERIALS AND METHODS
Materials
Synthetic oligonucleotides and chemical reagents were
obtained from TAGN and Sigma–Aldrich, respectively, unless
stated otherwise. MES was pre-treated with Dowex 1 · 2 chlo-
ride form before use, as preliminary experiments showed
inhibition of hPNK by the untreated buffer, presumably by
contaminating oligo(vinylsulfonic acid) as has been observed
for RNase A (19).
Cloning, expression and purification of
hPNK and mutants
The bacterial expression vector pETPNK was constructed by
cloning the coding sequence of human PNK, ampliﬁed from
vector kindly provided by Dr M. Weinfeld, into the NdeI and
BamHIsitesofpET28a(Novagen),withtheappropriaterestric-
tion sites being introduced at either end of the coding sequence
by PCR. Site-directed mutagenesis of the pETPNK plasmid
to obtain the K378A, D171A and D173A mutants was carried
out by the QuikChange (Stratagene) method. N-terminally
His-tagged wild-type and mutated hPNK were expressed in
EscherichiacoliRosetta2(DE3)pLysScells(Novagen)induced
with 1 mM isopropyl-b-D-thiogalactopyranoside (IPTG) for
3 h at 37 C. Puriﬁcation of proteins was carried out over a
Ni-NTA agarose (Qiagen) column according to the manufac-
turer’sdirections.Puriﬁedproteinsweresubsequentlydialysed
into buffer containing 50 mM HEPES (pH 7.8), 100 mM KCl,
1 mM EDTA, 1 mM DTT and 10% glycerol. Protein concen-
trationwasmeasuredbyultraviolet(UV)absorbanceat280nm
in 6 M guanidine using a calculated extinction coefﬁcient for
the His-tagged protein of 62 730 M
 1cm
 1.
Preparation of substrate
Fluorescently labelled oligonucleotides and the unlabelled
complementary strands were purchased from Eurogentec
and puriﬁed by denaturing PAGE in a 20% gel. The oligo-
nucleotides were annealed in 10 mM Tris (pH 7.5), 200 mM
NaCl and 1 mM EDTA before puriﬁcation in an 8% non-
denaturing polyacrylamide gel. The puriﬁed oligonucleotide
duplexes were ethanol precipitated and then redissolved at a
concentration of 500 nM in 10 mM Tris (pH 7.5), 200 mM
NaCl, 1 mM EDTA.
Activity assays
Double-strandedoligonucleotidesubstrates(50nM)wereincu-
bated with the indicated amounts of wild-type or mutated
hPNK for 10 min at 37 C in buffer containing 50 mM MES
(pH 6.0), 20 mM NaCl, 10 mM MgCl2, 0.1 mM ATP, 0.5 mM
EDTAand1mMDTT.Reactionswerequenchedbyadditionof
an equal volume of formamide loading buffer (10 mM EDTA,
98%formamide,10mg/mlbluedextran)andheatedto95 Cfor
3 min before loading on a 20% denaturing polyacrylamide gel.
Gels were visualized by ﬂuorimagery using a Typhoon 9410
laser scanning system (Amersham). All experiments were
repeated at least three times and representative gels are shown.
Competition experiments
Competitor oligonucleotide duplex was added at the indicated
concentrations to reaction mixtures containing a ﬂuorescently-
labelled double-stranded oligonucleotide with a recessed 50-
hydroxyl in buffer containing 50 mM MES (pH 6.0), 20 mM
NaCl, 10 mM MgCl2, 0.1 mM ATP, 0.5 mM EDTA and 1 mM
DTT. Reactions were initiated by addition of PNK D171A
mutant to a ﬁnal concentration of 4 nM. Following incubation
at 37 C for 8 min, the reactions were quenched by addition of
an equal volume of formamide loading buffer (10 mM EDTA,
98% formamide, 10 mg/ml blue dextran) and heated to 95 C
for 3 min before loading on a 20% denaturing polyacrylamide
gel. Gels were visualized by ﬂuorimagery using a Typhoon
9410 laser scanning system (Amersham). All experiments
were repeated at least three times and a representative gel
is shown. Band intensities were measured using ImageQuant
software and the amount of product generated in each case was
calculated as the intensity of the product band as a proportion
of the total intensities of the product and substrate bands.
Curve ﬁtting was carried out by non-linear regression using
SigmaPlot. The Ki is calculated as the distance between the
X-intercepts of the linear plots (20).
Nitrocellulose filter-binding assays
Nitrocellulose ﬁlter-binding assays were carried out in a Bio-
Dot SF slot blot apparatus using Hybond-ECL membrane
(GE Healthcare) pre-treated with 0.4 M KOH for 10 min,
washed and then equilibrated in binding buffer [50 mM
MES (pH 6.0), 20 mM NaCl, 10 mM MgCl2, 0.1 mM ATP,
1 mM DTT] for 1 h. Binding reactions containing binding
buffer, 100 pM FAM-labelled substrate and the indicated
amounts of enzyme were incubated on ice for 20 min before
application to the membrane. Slots were washed with 200 ml
of binding buffer and the membrane was then visualized by
ﬂuorimagery using a Typhoon 9410 laser scanning system.
Binding curves were plotted as the proportion of DNA
bound (corrected for non-speciﬁc binding to the ﬁlter) versus
the log of the protein concentration and ﬁtted by non-linear
regression using SigmaPlot. The Kd was calculated as the
concentration of enzyme which gave half maximal binding.
Repair by whole cell extracts
HeLa S3 cells were grown in adherent culture at 37 C and 5%
CO2 in MEM medium (Invitrogen) supplemented with 10%
FCS (Cambrex), 2 mM glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin (all Invitrogen). Whole cell extracts
were prepared from actively-dividing cells according to the
method of Tanaka (21) as modiﬁed by Vodenicharov (22) and
dialysed overnight against buffer containing 25 mM HEPES–
KOH (pH 7.9), 2 mM DTT, 12 mM MgCl2, 0.1 mM EDTA,
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stored at  80 C. Nicked substrate (25 nM) was incubated
at 37 C with 25 mg of whole cell extracts in 50 ml reactions
also containing 50 mM HEPES–KOH (pH 7.8), 50 mM KCl,
10 mM MgCl2, 0.5 mM EDTA, 1.5 mM DTT, 2 mM ATP,
0.4 mg/ml BSA, 25 mM phosphocreatine, 2.5 mg creatine
phosphokinase, 8.5% glycerol, 20 mM dNTPs, 0.2 mM
NAD
+ and 1 mg of single stranded competitor DNA. Aliquots
of 8 ml samples were removed at the indicated time points and
quenched by addition to an equal volume of formamide load-
ing buffer. The samples were then heated to 95 C for 3 min
before loading on a 20% denaturing polyacrylamide gel. Gels
were visualized by ﬂuorimagery using a Typhoon 9410 laser
scanning system (Amersham). All experiments were repeated
three times and a representative gel is shown.
Figure 1. Schematic representation of the substrates used in this study. PAGE-purified oligonucleotides were annealed according to the scheme above to give the
nicked, gapped and overhang substrates shown. The sequences (written 50–30) of the oligonucleotides used were FAM1: (6-FAM)TAGCATCGATCAGTCCTCp;
FAM2: (6-FAM) TAGCATCGATCAGTCCTC; TAMRA: GAGGTCTAGCATCGTTAGTCA(TAMRA); COMP1: TGACTAACGATGCTAGACCTCGAGG-
ACTGATCGATGCTA; COMP2: TGACTAACGATGCTAGACCTCTGAGGACTGATCGATGCTA; COMP3: TGACTAACGATGCTAGACCTCATCCGTT-
CAGTACGTAGG; COMP4: GTCTAGCTAGTTGTACGAACTGAGGACTGATCGATGCTA.
Figure 2. The phosphatase activity of hPNK is faster than its kinase activity in
processing a nick and a gap flanked by a 30-phosphate and a 50-hydroxyl. The
indicated double-labelled oligonucleotide duplexes (50 nM) were incubated
with wild-type hPNK at the concentrations shown for 10 min at 37 C. After
quenching, the samples were resolved in a 20% denaturing polyacrylamide gel
and analysed by fluorimagery.
Figure 3. Mutagenesis of the kinase domain leaves the phosphatase activity
of PNK unaffected. The indicated double-labelled oligonucleotide duplexes
(50 nM) were incubated with the hPNK K378A mutant at the concentrations
shown for 10 min at 37 C. After quenching, the samples were resolved in a
20% denaturing polyacrylamide gel and analysed by fluorimagery.
Figure 4. Mutagenesis of the phosphatase domain also abrogates the kinase
function of PNK. The indicated double-labelled oligonucleotide duplexes
(50 nM) were incubated with either (A) hPNK D171A or (B) hPNK D173A
at the concentrations shown for 10 min at 37 C. After quenching, the samples
were resolved in a 20% denaturing polyacrylamide gel and analysed by
fluorimagery.
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Processing of nicked and gapped substrates by hPNK
Double stranded oligonucleotide substrates were constructed
containing a 30-phosphate and 50-hydroxyl within either a nick
or a 1 nt gap and labelled at the 50 end with FAM and at the
30 end with TAMRA (Figure 1). Previous studies of PNK
activity on substrates containing both a 50-hydroxyl and a
30-phosphate have used a single
32P-label with the result
that one of the activities can often only be inferred through
the ligatability of the substrate (12,14). The use of two labels
allowed us to simultaneously characterize both kinase and
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incubation with the enzyme, the components of the double-
labelled substrate can be resolved by denaturing polyacry-
lamide gel electrophoresis prior to detection and quantitation
by two-channel ﬂuorimagery. Phosphatase-catalysed removal
of the 30-phosphate from the 6-FAM labelled oligonucleotide
results in its decreased mobility through a denaturing poly-
acrylamide gel while kinase addition of a 50-phosphate
increases the mobility of the TAMRA labelled species. It
has previously been demonstrated that the kinase activity of
mammalian PNKs has a signiﬁcant preference for 50-hydroxyl
termini associated with a nick or gap (23) and we could there-
fore assume minimal hPNK processing of the unlabelled com-
plementary strand.
We initially applied this system to compare the relative
activities of the phosphatase and kinase activities of hPNK in
processing of SSB containing both a 50-hydroxyl and a 30-
phosphate. Titration experiments revealed that the kinase
activity of hPNK was signiﬁcantly lower than its phosphatase
activity on both the nicked and gapped substrates (Figure 2).
While the phosphatase activity was able to process almost
all the substrate within 10 min at a hPNK concentration of
1 nM, the kinase activity showed comparably little substrate
turn-over at the same concentration. Since these experiments
were carried out under multiple-turnover conditions it can
be concluded that the kinase and phosphatase activites do not
act in a concerted manner on substrates containing both a
50-hydroxyl and a 30-phosphate. This might be expected given
the observed physical separation of the two active sites in the
enzyme structure (18) but is in marked contrast to T4 PNK.
The tetrameric structure of the phage enzyme, with the kinase
and phosphatase domains of adjacent monomers orientated
opposite each other, has been proposed to facilitate the simul-
taneous processing of a 50-hydroxyl and a 30-phosphate in the
same polynucleotide (24). Since T4 PNK is a tRNA repair
enzyme the differences in substrate processing between it and
the mammalian enzyme are likely to reﬂect their differing
roles in vivo, as recently discussed by Caldecott (25).
Disruption of the kinase active site does not affect the
phosphatase activity
While the amino acid sequence of the better-characterized
T4 PNK enzyme differs markedly from that of its mammalian
analogues, the active sites are well-conserved inboth sequence
and structure (18,24,26). This conservation of active site
morphology and the extensive site-directed mutagenesis
studies carried out on the T4 enzyme (27,28) provided a
basis for further exploration of the interdependence of the
two activities of PNK by selectively mutating each in turn.
We therefore mutated the Lys 378 amino acid of hPNK to
alanine to determine its importance for the kinase activity of
the enzyme. Lys 378 is located in the Walker A (P loop) motif,
which in the mouse enzyme has been shown to have a struc-
tural conﬁguration identical to that found in T4 PNK (18,24).
The homologous Lys 15 residue of T4 PNK was previously
shown to be essential for the kinase activity of the phage
enzyme (27) and is involved in ATP co-ordination (24,26).
We found that Lys 378 of the human enzyme was similarly
essential; with the kinase activity of the enzyme completely
abolished in the K378A mutant while the phosphatase activity
was unaffected (Figure 3).
Mutagenesis of the phosphatase active site disrupts
both phosphatase and kinase activities
We then characterized the effects of mutating residues in the
phosphatase active site on the repair activities of hPNK. The
amino acids selected for mutation were Asp 171 and Asp 173,
homologous respectively, to Asp 165 and Asp 167 of T4 PNK,
which have previously been shown to be essential for the
phosphatase activity of the T4 enzyme (27,28). While the
D171A mutation showed complete abrogation of phosphatase
function (Figure 4A), D173A showed residual activity at a
higher enzyme concentration of 20 nM (Figure 4B). This
reﬂects these residues’ proposed differing roles in catalysis.
Asp 171 is the ﬁrst aspartate in the conserved Dx(D/T)x
(T/V) phosphatase motif and forms the phosphoaspartate
intermediate essential to the reaction mechanism. In contrast,
Asp 173 has been proposed merely to aid dephosphoryla-
tion by acting as a general acid (18), protonating the alcohol
leaving group and also to be involved in regeneration of the
enzyme.
More unexpectedly, and in contrast to the K378A ﬁndings,
we found that mutation of the phosphatase domain also sig-
niﬁcantly disrupted the kinase activity on both nicked and
gapped substrates (Figure 4A and B). Despite the close asso-
ciation of the kinase and phosphatase domains in mammalian
PNK (18) itseemed unlikely that asingleaminoacidchange in
the phosphatase active site would affect the folding of that
of the kinase. These observations suggested that the kinase
activity was somehow dependent on the phosphatase activity.
Figure 5. Inhibition of kinase activity of phosphatase inactive mutants by 30-phosphorylated DNA. (A) hPNK mutant D171A readily phosphorylates substrates
lacking a 30-phosphate. The indicated oligonucleotide duplexes (50 nM) were incubated with hPNK D171A at the concentrations shown for 10 min at 37 C. After
quenching,thesampleswereresolvedina20%denaturingpolyacrylamidegelandanalysedbyfluorimagery.(B)3 0-Phosphorylatedoligonucleotideduplexinhibits
processingofkinasesubstratebyD171A.Oligonucleotideduplex‘Overhang’(50nM)wasincubatedwithhPNKD171A(4nM)for8minat37 Cinthepresenceof
varying concentrations of 30-phosphate-containing ‘Competitor’ duplex. After quenching, the samples were resolved in a 20% denaturing PAGE and analysed by
fluorimagery. Data points represent the mean, and error bars the standard deviation of three independent experiments. Curve fitting was carried out by non-linear
regressionusingSigmaPlot.TheKiiscalculatedasthedistancebetweentheX-interceptsofthelinearplots,whichrepresentlinesdrawnfromV,thehighestpointof
thecurve(i.e.intheabsenceofinhibitor),tocrossthecurveatV/2,V/3,V/4,V/5asdescribedbyDixon(20).(C)Nitrocellulosefilter-bindingassayshowsthatsingle
and double stranded 30-phosphorylated substrates are efficiently bound by D171A. Binding reactions contained 100 pM FAM-labelled double-stranded
(ds, ‘Overhang’, Figure 1) or single-stranded (ss, FAM1, Figure 1) substrate and concentrations of hPNK D171A ranging from 0.1–81 nM. The extent of binding
was measured by nitrocellulose filter binding assay as detailed in the Materials and Methods section. Data points represent the mean, and error bars the standard
deviation of three independent experiments. (D) Optimal inhibition is obtained with a recessed 30-phosphate. Oligonucleotide duplex ‘Overhang’ (50 nM) was
incubated with hPNK D171A (4 nM) for 8 min at 37 C in the presenceof the indicatedcompetitors (10 nM), where an asteriskcorrespondsto a 30-phosphate. After
quenching,thesampleswereresolvedina20%denaturingPAGEandanalysedbyfluorimagery.Datapointsrepresentthemean,anderrorbarsthestandarddeviation
of three independent experiments.
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depends on the presence of a 30-phosphate in the
substrate
To test this hypothesis we examined the ability of a phos-
phatase mutant to 50-phosphorylate substrates in which a
30-phosphate is absent. We tested the activity of the D171A
mutant on a substrate containing a recessed 50-hydroxyl with a
30-overhang (‘Overhang’, Figure 1) and a substrate containing
an i c kﬂ a n k e db yb o t h5 0-a n d3 0-hydroxyls (‘Nick2’, Figure 1).
We found that the kinase activity of the D171A mutant was
able to efﬁciently phosphorylate both of these substrates
(Figure 5A). We therefore concluded that the observed
disruption of the kinase activity on the previous substrates
was indeed due to the presence of the 30-phosphate. Our results
also indicated that hPNK shows similar kinase processing of a
50-hydroxylwhetherlocatedwithinanickorarecess andarein
good agreement with the ﬁndings of Bernstein et al. (18).
There are two possible models whereby the presence of a
30-phosphate in the substrate could inhibit kinase activity:
(i) the kinase domain is able to discriminate between phos-
phorylated and unphosphorylated substrates and only binds/
processes the latter and (ii) phosphorylated substrate is bound
by the phosphatase domain and on binding prevents other
substrates from accessing the kinase domain. A third possi-
bility, that the substrate is preferentially bound by the
phosphatase domain and therefore cannot be accessed by
the kinase domain can be discounted since these experiments
were all carried out under conditions of excess substrate.
In order to discriminate between these two mechanisms
we examined the effects of titrating a competing substrate
(‘Competitor’, Figure 1) containing a recessed 30-phosphate
and 50-overhang into reactions containing the D171A mutant
and the 30-overhang substrate. If the ﬁrst model were correct
then the processing of the 30-overhang substrate would be
unaffected by the titration. However, if the second model
were correct then addition of the competing substrate would
result in inhibition of kinase activity.
The results of the titration experiments (Figure 5B) revealed
the second model to be the case and that where a 50-hydroxyl
and a 30-phosphate are both present, processing of the 30-
phosphate takes precedence. The kinase activity showed
almost stoichiometric inhibition by the 30-phosphorylated
competitor. Using the graphical method developed by
Dixon (20) for analysis of tight binding inhibitors
(Figure 5B) and assuming mixed inhibition with a predomi-
nantly competitive component we were able to estimate the Ki
for the 30-phosphorylated competitor as being <0.6 nM. This
tight binding of the phosphatase domain to its substrate is
consistent with the observation that the phosphatase activity
precedes that of the kinase. By comparison, the binding of
the kinase domain to a sub-optimal single stranded substrate
was recently found to be 1.3 mM (29).
We then compared the ability of different 30-phosphorylated
substrates to inhibit the kinase activity of the D171A mutant.
We initially conﬁrmed via nitrocellulose ﬁlter-binding experi-
ment that hPNK mutant D171A was able to efﬁciently bind
both single and double stranded substrates (Figure 5C). As
predicted by Bernstein etal. (18) who showed that mammalian
PNK dephosphorylates 30-phosphorylated nicks, gaps and
single stranded substrates equally well, we found that both
single (Kd   1.9 nM) and double stranded (Kd   1.2 nM)
substrates were tightly bound by the mutant enzyme. This
ﬁnding correlates well with the proposed model for phos-
phatase substrate binding in which only the ﬁrst three back-
bone phosphates of the substrate contribute to binding at the
phosphatase surface (18).
When we tested the ability of the different phosphatase
substrates to inhibit D171A kinase activity, we found that
inhibition was affected by the length of the 50-overhang,
with inhibition progressively decreasing as the size of the
overhang decreased (Figure 5D, compare inhibitors i–iii).
Inhibitor containing a 30-overhanging phosphate (iv) or a
single stranded inhibitor (v) were both unable to substanti-
ally inhibit the kinase activity. We also conﬁrmed that
effective inhibition required the presence of a 30-phosphate
(inhibitor vi).
Taken together, these results strongly suggest that the
observed kinase inhibition arises as a result of steric hindrance
by the phosphatase substrate rather than through allosteric
restructuring of the enzyme. Inhibitors (iv) and (v), in
which the 30-phosphate is present on single stranded DNA,
will have more conformational ﬂexibility than inhibitors
(i–iii) where the 30-phosphate is constrained at the end of a
Figure 6. Wild-type PNK has inhibited kinase and phosphatase activity on a
nicked substrate containing a 30-phosphorothioate monoester. (A) Double-
labelled nicked duplexes containing a 50-hydroxyl and either a 30-phosphate
or a 30-phosphorothioate monoester (50 nM) were incubated with wild-type
hPNK (5 nM) for the indicated times. After quenching, the samples were
resolvedina20%denaturingpolyacrylamidegelandanalysedbyfluorimagery.
(B) Kinetics of hPNK kinase activity on 30-phosphorylated or -thiophosphory-
lated substrates. Data points represent the mean, and error bars the standard
deviation of three independent experiments.
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access the kinase active site.
The phosphatase activity of the wild-type enzyme also
precedes the kinase
It was important to determine whether the results obtained for
the phosphatase inactive mutant could be extrapolated to the
wild-type enzyme. If so, it might be expected that a nick
containing a 30-phosphate would be phosphorylated by the
kinase activity less efﬁciently than a nick without a phosphate.
In practice however, we found that the phosphatase activity
of hPNK was so much faster than the kinase activity that the
30-phosphorylated nick was effectively transformed into an
unphosphorylated nick and so no difference in kinase activity
was observable (data not shown).
We therefore employed a modiﬁed nicked substrate,
substituting the 30-phosphate with a 30-phosphorothioate
monoester in which one of the non-bridging phosphate oxy-
gens has been replaced with sulfur. While this is a fairly
conservative change structurally, phosphorothioates show
important differences in reactivity compared to phosphates:
the negative charge localizes to the sulfur and the phosphorus
is less electrophilic. Accordingly, it has been shown that
thiophosphorylated proteins are relatively resistant to
dephosphorylation by protein phosphatases when compared
to normal phosphoproteins (30).
We treated the 30-phosphorothioate nick with wild-type
hPNK and found that the phosphatase activity indeed hydrol-
ysed the phosphorothioate more slowlythan the corresponding
phosphate (Figure 6A, FAM panels), presumably due to less
ready formation of the phosphoaspartate intermediate with
Asp 171. This decrease in phosphatase activity was accom-
panied by a decrease in kinase activity (Figure 6A, TAMRA
panels and 6B) and therefore recapitulated the mutagenesis
results. It can thus be concluded that 50-phosphorylation of
strand breaks containing a 30-phosphate and 50-hydroxyl
depends on prior processing by the phosphatase activity of
hPNK.
The kinase activity of hPNK is rate-limiting in cell
extract-mediated repair
Our results suggested that the kinase activity of hPNK might
be rate-limiting in the in vivo repair of nicks containing
30-phosphate and 50-hydroxyl. However, it is known that
PNK-dependent repair of SSB is stimulated by the presence
of other repair factors, such as XRCC1 (14) and Ligase I (12).
We therefore examined the repair of a nicked substrate by
HeLa whole cell extracts (Figure 7), in this case substituting
a Cy5 label for the 6-FAM label previously used, since pre-
liminary experiments revealed 6-FAM to be labile in cell
extracts. We found that while the phosphatase product accu-
mulated during the course of the reaction the kinase product
did not and was instead immediately processed to yield the
double-labelled 39 bp product of strand ligation (Figure 7).
We therefore concluded that the kinase activity of PNK is
indeed rate-limiting in the repair of this type of strand break.
Strand breaks with 30-phosphate and 50-hydroxyl termini
arise through the Tdp1 processing of abortive topoisomerase
I complexes, such as are generated by the anti-neoplastic drug
camptothecin. A role for PNK in processing camptothecin-
induced DNA damage has long been proposed (2) and was
recently demonstrated by RNAi knockdown of hPNK (16). It
was also recently shown that hPNK is present in vivo as part of
a multi-enzyme complex with Tdp1(15). Our results suggest
that hPNK mediated phosphorylation of the 50-hydroxyl
terminus would be a key modulating factor in determining
the efﬁciency of repair of these lesions.
The reason for giving precedence to the phosphatase
domain over the kinase domain may lie in the relative impor-
tance of the two activities in protecting against DNA damage.
Ionising radiation, for example, generates substantially more
30-phosphate termini than 50-hydroxyl termini. Similarly, the
Figure 7. The kinase activity of PNK is rate-limiting in the repair of a nick flanked by a 30-phosphate and a 50-hydroxyl. Double-labelled oligonucleotide duplex
(25 nM) was incubated with 25 mg of HeLa S3 whole cell extract at 37 C for the indicated times. After quenching, the samples were resolved in a 20% denaturing
polyacrylamide gel and analysed by fluorimagery.
2236 Nucleic Acids Research, 2006, Vol. 34, No. 8PNK-dependent sub-pathway of BER initiated by bifunctional
glycosylases requires only the phosphatase activity of PNK
(3). Furthermore, while a 30-phosphate completely blocks
repair synthesis by being non-processible by both DNA poly-
merases and ligases, a 50-hydroxyl only blocks ligation and
could theoretically be bypassed by extending DNA synthesis.
Although it has been reported that the optimal substrate for the
repair polymerase Pol b is a 1 nt gap containing a 50-phosphate
(31), it is possible that it or another polymerase could displace
the 50-hydroxyl in a ﬂap, which could then be excised by
FEN-1 in a mechanism analogous to that employed in the
long-patch sub-pathway of base excision repair (32).
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